The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, X.
Right arrow Articles by Rodriguez, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, X.
Right arrow Articles by Rodriguez, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 1999, 162: 17-24.
Copyright © 1999 by The American Association of Immunologists

A Theiler’s Virus Alternatively Initiated Protein Inhibits the Generation of H-2K-Restricted Virus-Specific Cytotoxicity1

Xiaoqi Lin*,{dagger}, Raymond P. Roos{ddagger}, Larry R. Pease*, Peter Wettstein* and Moses Rodriguez2,*,{dagger}

Departments of * Immunology and {dagger} Neurology, Mayo Clinic, Rochester, MN 55905; and {ddagger} Department of Neurology, University of Chicago Medical Center, Chicago, IL 66906

In susceptible mouse strains, the wild-type Daniel’s (wt-DA) strain of Theiler’s murine encephalomyelitis virus induces a persistent central nervous system (CNS) infection with chronic demyelination. The virus is cleared from resistant mice with no resulting demyelination. We characterized the role of the DA L* protein in late demyelination and persistent infection. The DA genome has two alternative reading frames, encoding the virus polyprotein and L*, respectively. The mutant virus DAL*-1 fails to synthesize L* and does not persist in the CNS of wt-DA-susceptible SJL/J or B10.S mice. Since class I-restricted cytotoxicity has been shown to determine resistance to virus persistence and demyelination in this model, virus-specific cytotoxicity in the CNS of DA-resistant (B6 or B10) and -susceptible (SJL/J and B10.S) mice during the acute stage of DA and DAL*-1 infection was characterized. Following intracerebral inoculation with DAL*-1, virus-specific Db- and Kb-restricted CTLs were demonstrated in the CNS of resistant B10 mice, whereas only Db-restricted CTL were found in wt-DA-inoculated mice. CTLs specific to wt-DA or DAL*-1 recognized class I-presented peptides from either of the viruses. Of particular interest, Ks-restricted virus-specific cytotoxicity-restricted CTLs were identified in the CNS of susceptible SJL/J (H-2s) and B10.S (H-2s) mice inoculated with DAL*-1. In contrast, no virus-specific CTLs were identified in the CNS of SJL/J and B10.S mice inoculated with wt-DA. We propose that L* inhibits the generation of H-2K-restricted virus-specific cytotoxicity in the CNS, permitting a persistent infection in susceptible strains, with subsequent inflammatory demyelination in the CNS similar to that in human multiple sclerosis.




This article has been cited by other articles:


Home page
Int ImmunolHome page
X. Lin, X. Ma, M. Rodriguez, and R. P. Roos
CD4+ T cells are important for clearance of DA strain of TMEV from the central nervous system of SJL/J mice
Int. Immunol., September 1, 2004; 16(9): 1237 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
X. Lin, X. Ma, M. Rodriguez, X. Feng, L. Zoecklein, Y.-X. Fu, and R. P. Roos
Membrane lymphotoxin is required for resistance to Theiler's virus infection
Int. Immunol., August 1, 2003; 15(8): 955 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Asakura, H. Murayama, T. Himeda, and Y. Ohara
Epitope-Tagged L* Protein of Theiler's Murine Encephalomyelitis Virus Is Expressed in the Central Nervous System in the Acute Phase of Infection
J. Virol., November 13, 2002; 76(24): 13049 - 13054.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. van Eyll and T. Michiels
Non-AUG-Initiated Internal Translation of the L* Protein of Theiler's Virus and Importance of This Protein for Viral Persistence
J. Virol., October 2, 2002; 76(21): 10665 - 10673.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B.-S. Kang, M. A. Lyman, and B. S. Kim
The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional
J. Virol., June 5, 2002; 76(13): 6577 - 6585.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. D. Murray, D. B. McGavern, S. Sathornsumetee, and M. Rodriguez
Spontaneous remyelination following extensive demyelination is associated with improved neurological function in a viral model of multiple sclerosis
Brain, July 1, 2001; 124(7): 1403 - 1416.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Deitz, D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A
PNAS, November 22, 2000; (2000) 250483097.
[Abstract] [Full Text]


Home page
J. Virol.Home page
O. van Eyll and T. Michiels
Influence of the Theiler's Virus L* Protein on Macrophage Infection, Viral Persistence, and Neurovirulence
J. Virol., October 1, 2000; 74(19): 9071 - 9077.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. Obuchi, J. Yamamoto, T. Odagiri, M. N. Uddin, H. Iizuka, and Y. Ohara
L* Protein of Theiler's Murine Encephalomyelitis Virus Is Required for Virus Growth in a Murine Macrophage-Like Cell Line
J. Virol., May 15, 2000; 74(10): 4898 - 4901.
[Abstract] [Full Text]


Home page
J. Virol.Home page
K. Yamasaki, C. C. Weihl, and R. P. Roos
Alternative Translation Initiation of Theiler's Murine Encephalomyelitis Virus
J. Virol., October 1, 1999; 73(10): 8519 - 8526.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. J. Johnson, M. K. Njenga, M. J. Hansen, S. T. Kuhns, L. Chen, M. Rodriguez, and L. R. Pease
Prevalent Class I-Restricted T-Cell Response to the Theiler's Virus Epitope Db:VP2121-130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28
J. Virol., May 1, 1999; 73(5): 3702 - 3708.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. B. Deitz, D. A. Dodd, S. Cooper, P. Parham, and K. Kirkegaard
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A
PNAS, December 5, 2000; 97(25): 13790 - 13795.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.